By: Alvaro Fernandez
?On aver?age, the med?ica?tions pre?scribed for brain-related con?di?tions ben?e?fit approx?i?mately 50% of patients. ?But which?50%?.?
?We need unam?bigu?ous bio?mark?ers that are clin?i?cally rel?e?vant and scal?able at rea?son?able cost.?They already exist in Can?cer. ??But they do not yet exist in the Brain.? What may change that?
We are hon?ored to bring to Sharp?Brains read?ers a new series of arti?cles sum?ma?riz?ing the state of Per?son?al?ized Med?i?cine, and explor?ing its emerg?ing impact on brain health, men?tal health and brain fit?ness.? The series, writ?ten by Dr. Evian Gor?don, draws on his recent pre?sen?ta?tion at the Per?son?al?ized Med?i?cine World Con?gress (PMWC)?on Jan?u?ary, 23, 2012 at Stan?ford Uni?ver?sity, and on the very exten?sive set of con?ver?sa?tions held dur?ing the Congress.
New Series on Per?son?al?ized Med?i?cine and the Brain:
- Mon?day, Feb?ru?ary 13th: The State of Per?son?al?ized Medicine
- Mon?day, Feb?ru?ary 20th: Chal?lenges and Oppor?tu?ni?ties of?Per?son?al?ized Med?i?cine in Psychiatry
- Mon?day, Feb?ru?ary 27th: Work?ing with?Health Care Indus?try Stake?hold?ers?Towards?Brain-based Per?son?al?ized Medicine
?
Categories: Cognitive Neuroscience, Health & Wellness
Tags: biomarkers, brain, Brain-health, health care, Integrative Neuroscience, medications, Mental-Health, Personalized Medicine World Congress, personalized-medicine, psychiatry
ufc 143 results superbowl halftime show patriots vs giants super bowl superbowl national anthem papa johns guacamole recipe jason wu for target
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.